ABOUT WORLDWIDE CLINICAL TRIALS
Worldwide Clinical Trials (Worldwide) is a leading global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications, from discovery to reality. Our full-service clinical development capabilities include bioanalytical laboratory services and Phase I-IV clinical trials, as well as post-approval and real-world evidence studies – all powered by our talented and accessible team of clinicians, scientists, and researchers who bring their first-hand expertise to each clinical program.
At Worldwide, we understand that each customer and project are unique, so we take a collaborative and personalized approach to identify and meet specific needs and goals. Anchored in our company’s scientific heritage, we are therapeutically focused on cardiovascular, metabolic, neuroscience, oncology, and rare diseases. We apply this deep therapeutic knowledge to develop flexible plans and quickly solve problems in the rapidly evolving clinical development landscape.
Our team of 3,000+ professionals spans 60+ countries, and believes that through collaboration, and a culture that embraces diversity, equity, inclusion, and belonging (DEI&B), everyone plays an important role in making a world of difference for patients and their caregivers. We are united in cause with our customers to improve the lives of patients through new, innovative therapies.
For more information on Worldwide, visit www.Worldwide.com or connect with us on LinkedIn.
FEATURED ARTICLES
-
![WWCT]( "Operational Solutions For Seamless Cohort Management & Dose Escalation Studies")
Operational Solutions For Seamless Cohort Management & Dose Escalation StudiesJim Eamma’s experience in scientific and clinical research includes work in academic, clinical, and CRO settings. Jim shares more about Worldwide Clinical Trials and how the team can help with your oncology trials.
-
![GettyImages-1173740575 computer research data]( "Successful Special Procedure Study Conduct: Cerebrospinal Fluid (CSF) And Concurrent Muscle Biopsy")
Successful Special Procedure Study Conduct: Cerebrospinal Fluid (CSF) And Concurrent Muscle BiopsyWorldwide assisted a trial sponsor with a study exploring a novel therapeutic protein (TP) in 48 healthy volunteers.
-
![GettyImages-1039397968 trial timing]( "Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key Endpoints")
Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key EndpointsA pharmaceutical company enlisted Worldwide Clinical Trials to help achieve on-time results for their Phase IIa IPF clinical trial, enabling them to manage vendors and meet challenging deadlines.
-
![trial-CRO-meeting-GettyImages-1206260023]( "Precision Partnerships: Your Guide To Selecting The Right CRO")
Precision Partnerships: Your Guide To Selecting The Right CROWhat do you need to know to select the right CRO partner to provide your study with the expertise, resources, and support needed for successful trial execution?
-
![GettyImages-1372859699 antibodies]( "Bispecific Antibody PK And ADA Bioanalysis: An Experienced Approach")
Bispecific Antibody PK And ADA Bioanalysis: An Experienced ApproachThis article outlines a strategic approach to address these bioanalytical challenges for BsAbs, ensuring accurate and reliable assessment of safety and efficacy.
-
![bioanalytical lab]( "Bioanalytical Lab: A Trusted Market Leader In Bioanalysis")
Bioanalytical Lab: A Trusted Market Leader In BioanalysisLearn about Worldwide Clinical Trials and their bioanalytical lab's ability to accommodate analysis based on your study’s requirements.
-
![GettyImages-645455610 doctor, liver]( "Metabolic Dysfunction-Associated Steatohepatitis (MASH) Clinical Program Design")
Metabolic Dysfunction-Associated Steatohepatitis (MASH) Clinical Program DesignExplore the evolving landscape of metabolic dysfunction-associated steatohepatitis (MASH), including key trial considerations and factors influencing the development of new treatments.
-
![GettyImages-479821950 dose]( "Managing Tomorrow's Responses Today — Delayed Outcomes In Dose Escalation Trials")
Managing Tomorrow's Responses Today — Delayed Outcomes In Dose Escalation TrialsLearn how innovative clinical trial designs can help in the optimal development of new immunological targets and combination therapies, ensuring that advancements continue to benefit patients.
-
![GettyImages-1175131167 cancer]( "Optimizing Site And Patient Engagement In An Oncology Transition Study")
Optimizing Site And Patient Engagement In An Oncology Transition StudyA small biotech faced challenges with their study, including sluggish recruitment, inadequate site engagement, and delays in data entry. Find out how they were able to overcome these challenges.
-
![scientist analyzing test tube of medicine in laboratory]( "Strategic Considerations For Success In Gene-Based Therapeutics Development")
Strategic Considerations For Success In Gene-Based Therapeutics DevelopmentThe forces that impact gene therapy development continue to evolve dramatically. This paper explores strategic considerations for regulatory, operational, and commercial success.
CONTACT INFORMATION
Worldwide Clinical Trials
600 Park Offices Drive Suite 200
Research Triangle Park, NC 27709
UNITED STATES
Phone: 919-674-2900
Contact: Mary Gelovich
BROCHURES
- Cardiovascular Clinical Development
- Game Changers In Clinical Trials: The Power Of Top- Performing Project Managers
- Addressing Top Concerns And Unmet Needs In Oncology Research
- CGT Development At Worldwide Clinical Trials
- Site Alliances: The Power Of Site Engagement
- Make Informed Decisions, Faster
- Adaptive Trial Design — Is It Right For Your Clinical Study?
- Keeping NDA On Schedule After Unexpected FDA Feedback
WEBINARS
This webinar will explore the RWE/RWD landscape and focus on those situations in which a prospective observational study or registry presents a more optimal solution.
Check out Worldwide's latest on-demand webinar focusing on clinical pharmacology trends. Experts discuss topics like shifts in formal drug testing and approval processes, combining of single and multiple ascending dose studies, and advanced statistical methodology.